CYBERONICS INC (CYBX)

HEALTH CARE: HEALTH CARE
SIC: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

100 CYBERONICS BLVD HOUSTON, TX 77058

Cyberonics designs, develops, makes and markets medical devices for the treatment of epilepsy and other debilitating neurological disorders using vagus nerve stimulation. In 1997, the company received approval from the FDA to market its VNS Therapy System in the U.S. as an adjunctive therapy for epilepsy.

View SEC Filings from CYBX instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 0 0 (0.0%)
13F Filers holding this stock: 2 0 (0.0%)
Aggregate 13F shares on 03/31/2020: 1 0
Aggregate 13F shares on 12/31/2019: 1 0
Percent change: 0.00%
Funds creating new positions:
Funds Adding to an existing position:
Funds closing out their position:
Funds reducing their position:
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding CYBX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CYBX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MOORE DANIEL JEFFREY

  • Director
0 2020-06-29 0

MORRISON HUGH M

  • Director
0 2020-06-29 0

NOVAK ALFRED J

  • Director
0 2020-06-29 0

ROSENTHAL ARTHUR L

  • Director
0 2020-06-29 0

VERRATTI MARK PRESIDENT ASSUREX HEALTH INC.

  • Officer
79,059 2019-09-30 0

TREMMEL JON T

  • Director
23,205 2019-09-21 0

SCHWARZ JEFFREY E CHAIRMAN AND CEO

  • Officer
  • Director
  • 10% Owner
1,131,649 2019-07-16 0

WISE DAVID S CHIEF ADMINISTRATIVE OFFICER

  • Officer
27,929 2019-01-15 0

REINSTEIN JAMES A. PRESIDENT AND CEO

  • Officer
  • Director
134,445 2019-01-02 0

GUTEDEL JACQUES PRESIDENT INTERCONTINENTAL

  • Officer
No longer subject to file 2016-08-09 0

JACKSON GUY C.

  • Director
44,707 2015-11-24 0

BROWNE GREGORY H SR VP FINANCE & CFO

  • Officer
No longer subject to file 2015-10-19 0

LAPTEWICZ JOSEPH E

  • Director
No longer subject to file 2015-10-19 0

ALCH DARREN VP GENL COUNSEL ASST SEC

  • Officer
No longer subject to file 2015-10-19 0

HOARE ROHAN PRESIDENT, NEUROMODULATION

  • Officer
7,505 2015-10-19 0

MORRIS MILTON MAYO

  • CONSULTANT
No longer subject to file 2015-04-29 0

SIMPSON RANDAL L VP OPERATIONS

  • Officer
No longer subject to file 2014-06-15 0

KENKNIGHT BRUCE H VP, EMERGING THERAPIES

  • Officer
No longer subject to file 2014-06-15 0

OLIN BRYAN D VP CLINICAL QUALITY REGULATORY

  • Officer
No longer subject to file 2014-06-11 0

PERKINS SHERRIE L VP, MKTG & NBD

  • Officer
24,161 2013-11-25 0

TERRY REESE S JR

  • Director
373,307 2010-06-10 0

OLSEN ALAN J

  • Director
13,432 2009-06-26 0

PARKER GEORGE E VP, HR

  • Officer
  • FORMER VP, HR
No longer subject to file 2009-06-01 0

STRAUSS MICHAEL J MD

  • Director
24,682 2008-06-26 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments